Ziwen Zhang
Jiaxing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Nano-Engineered Dressings for Infected Diabetic Wounds: Synergy of Catalysis, Delivery, and Fluid Management.
Journal: International journal of nanomedicine
Published: May 27, 2026
Extracellular Vesicles in Gestational Diabetes Mellitus: Pathogenesis, Diagnosis, and Therapy.
Journal: International journal of nanomedicine
Published: April 09, 2026
Placenta-derived small extracellular vesicles transfer miR-520d-5p to mediate pancreatic β-cell injury in gestational diabetes mellitus by targeting SIRT1.
Journal: BMC pregnancy and childbirth
Published: January 12, 2026
Discovery and structure-activity relationship of cannabidiol aminoquinones as anti-Alzheimer's agents via dual modulation of Nrf2/HO-1 and TLR4/NF-κB pathways.
Journal: Bioorganic chemistry
Published: November 23, 2025
Advances in Nanomedicine-Mediated Modulation of the Microbiome for Cancer Therapy.
Journal: International journal of nanomedicine
Published: August 03, 2025
Interferon-Driven Biomarkers and Synergistic Therapy for PRMT5 Inhibition in Triple-Negative Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 01, 2025
An aptamer-drug conjugate for promising cancer therapy with comprehensive evaluation from rodents to non-human primates.
Journal: Signal transduction and targeted therapy
Published: February 11, 2025
Perivascular Niche-Resident Alveolar Macrophages Promote Interstitial Pneumonitis Related to Trastuzumab Deruxtecan Treatment.
Journal: Cancer research
Published: June 20, 2024
Dual-modal imaging-guided agent based on NIR-II aggregation-induced emission luminogens with balanced phototheranostic performance.
Journal: Chemical science
Published: March 22, 2024
A pH-responsive ZC-QPP hydrogel for synergistic antibacterial and antioxidant treatment to enhance wound healing.
Journal: Journal of materials chemistry. B
Published: September 20, 2023
Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer.
Journal: Cancer
Published: September 20, 2023
Last Updated: 09/26/2026